Prevalence and impact of TWILIGHT criteria in all-comer patients undergoing percutaneous coronary intervention

Back

ESC Professional Premium Access

Prevalence and impact of TWILIGHT criteria in all-comer patients undergoing percutaneous coronary intervention

Session: Pharmacology and bleeding/ischaemica trade-off

Topic: Outcome

Speaker: Doctor W. Koh (New York, US)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Doctor Won-Joon Koh

Mount Sinai Hospital, New York (United States of America)

0 follower

6 more presentations in this session

Early in-hospital discontinuation of aspirin following coronary stent implantation in patients with indication for direct oral anticoagulation

Speaker: Doctor P. von Stein (Cologne, DE)

Access

Abstract

Slides

Bleeding in patients undergoing percutaneous coronary intervention: factors associated with procedural outcomes and major bleeding complications

Speaker: Doctor T. Bimal (Port Jefferson, US)

Access

Abstract

Slides

Determinants of myocardial injury following transcatheter aortic valve implantation: a pre-specified substudy from the POPular TAVI trial

Speaker: Mr D. van Ginkel (Nieuwegein, NL)

Access

Abstract

Slides

Dual versus single antiplatelet therapy after transcatheter aortic valve replacement: a systematic review and meta-analysis

Speaker: Doctor R. Eikelboom (Hamilton, CA)

Access

Abstract

Slides

Reduction of major adverse and major cardiovascular events in patients with atrial fibrillation and stent implantation treated with left atrial occlusion device vs oral anticoagulants strategy.

Speaker: Professor J. Lopez-Minguez (Badajoz, ES)

Access

Abstract

Slides

Access the full session

Pharmacology and bleeding/ischaemica trade-off

Speakers: Doctor W. Koh, Doctor P. von Stein, Doctor T. Bimal, Mr D. van Ginkel, Doctor R. Eikelboom...

Access

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources